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Abstract
With rapidly increasing globalization, trends towards unhealthy diets, obesity, sedentary lifestyles and unhealthy
habits are resulting in an increased worldwide burden of chronic non-communicable diseases (NCDs). In Africa this
means that health systems face the challenge of an increasing burden of NCDs and of continuing high morbidity
and mortality from communicable diseases. This health transition represents an enormous challenge to Africa as
the region with the least resources for an effective response. Whereas previous epidemics, including HIV, have
caught Africa unprepared, the opportunity now arises to take the advancing wave of health transition in Africa
seriously. Health research has a key role to play in meeting health and development goals, and must be responsive
to changing disease patterns, such as health transition. There is an urgent need for research on health transition in
Africa to enable countries to respond effectively to rapidly changing health needs.
Key areas of research include the following: epidemiological research so that a good understanding of the
distribution in Africa of communicable and non-communicable diseases can inform health planning; research on
the interactions between communicable and non-communicable diseases; health system research with a particular
focus on new approaches to improve the primary care response to health transition; and policy research to
evaluate the more upstream measures addressing the population-level determinants of NCDs. It is time to
capitalise on the global policy environment, which is becoming more favourable to action on health transition in
Africa, and implement a research agenda for health transition. Alliances have a key role to play in Africa as well as
in other regions in implementing the research agenda on health transition by building research capacity and
mobilizing the necessary investments.
Introduction
These are exciting times for health research in develop-
ing countries, with increasing consensus on the role of
research in meeting health and development goals [1,2].
The health research agenda needs to be responsive to
changing disease patterns. Rapidly increasing globaliza-
tion is accompanied by an increased worldwide burden
of chronic non-communicable diseases (NCDs), includ-
ing in developing countries. Sub-Saharan Africa faces
particular challenges in responding to health transition,
i.e. a double burden of communicable and non-commu-
nicable diseases. Health transition represents an enor-
m o u sc h a l l e n g et oA f r i c aa st h er e g i o nw i t ht h el e a s t
resources for an effective response. Whereas previ-
ous epidemics, including HIV, have caught Africa
unprepared, the opportunity now arises to take the
advancing wave of health transition in Africa seriously.
In this paper we highlight the urgent need for research
to enable countries in Africa to respond effectively to
rapidly changing health needs. Key research areas
include the following: research on the interactions
between communicable and non-communicable dis-
eases; epidemiological research so that a good under-
standing of the distribution in Africa of communicable
and non-communicable diseases can inform health plan-
ning; health delivery research with a particular focus on
new approaches to improve the primary care response
to health transition; and policy research to evaluate the
more upstream measures addressing the population-
level determinants of NCDs.
Discussion
With rapidly increasing globalization, trends towards
unhealthy diets, sedentary lifestyles and unhealthy habits
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chronic NCDs (e.g. diabetes, cardiovascular and lung
diseases, and cancer) and their associated risk factors
(e.g. smoking, alcohol, hypertension, and obesity). While
all low- and middle-income regions face the challenge
of NCDs as increasingly important health problems, the
African region faces the particular problem of an
increasing burden of NCDs [3,4] and of continuing high
morbidity and mortality from communicable diseases.
Uganda provides an illustrative example of a resource-
poor country in Africa in epidemiological transition.
There is a continuing high burden of communicable dis-
eases, with for example national estimates for 2007 of
5.4% HIV prevalence [5] and of tuberculosis incidence
of 330/100,000 per year [6]. The importance of NCDs is
increasingly recognized. The estimated national preva-
lence of diabetes was 98,000 in 2000 and is expected to
rise to 328,000 by 2030 [7]. The prevalence of diabetes
is particularly high in urban areas, with estimates sug-
gesting that as many as 8% of the residents of the capi-
tal, Kampala, might have type 2 diabetes [8]. The
estimated number of deaths in 2004 due to cardiovascu-
lar disease in Uganda was around 34,000 of which about
10,000 were attributable to ischaemic heart disease and
around 12,000 to cerebrovascular disease [9].
Research on health transition is important because it
imposes considerable costs on individuals, families and
communities. Communicable diseases impose heavy
human costs in terms of suffering and death, and also
heavy financial costs on poor households. As NCDs
become increasingly important causes of morbidity and
mortality in developing countries, especially in Africa,
they also incur high costs both to the individual and
national economies [10]. Chronic NCDs have a huge
negative economic impact and represent a significant
impediment to human development in low- and middle-
income countries [11]. In addressing inequalities in
health in Africa, the agenda for research on health tran-
sition needs not only to maintain a focus on HIV and
other communicable diseases but also to expand to
include research on NCDs and on the interactions
between communicable diseases and NCDs.
Research on the interactions between communicable and
non-communicable diseases
An increasing burden of disease in Africa arises not only
from communicable diseases and NCDs but also from
the interactions between them, e.g. between tuberculosis
and malnutrition, human papilloma virus and cervical
cancer, and hepatitis B virus and hepatoma. The burden
of chronic NCDs (including for example diabetes) is
likely to be further uncovered as scaled-up programmes
of antiretroviral treatment (ART) of HIV-infected people
lead to reduced HIV/AIDS mortality but increased
morbidity related to chronic HIV infection and ART
[12]. Increasing numbers of people in Africa are there-
fore at risk of possible metabolic side-effects resulting
from life-long ART, but there is little knowledge of their
epidemiology [13,14] or of how health systems can most
effectively address them. Research on health transition
in Africa needs to include research on the interactions
between communicable diseases and NCDs: the biology
of their interaction, their clinical course and distribu-
tion, and the delivery of interventions aimed at their
prevention and treatment.
Epidemiological research
Planning an improved health system response to health
transition, with a priority for primary health care [15],
requires assessment of the population burden not only
of communicable diseases but also of NCDs and asso-
ciated risk factors [16]. For example, the WHO STEP-
wise approach to surveillance of NCD risk factors uses a
standard survey instrument and a methodology that can
be adapted in different settings [17]. A lack of high
quality health information is one of the major obstacles
in developing appropriate preventative strategies for
NCDs at the national level [18]. The need for good
quality comparable data on disease burden and risk, to
aid planning and implementation of prevention and
control strategies for NCDs, is greatest among low- and
middle-income countries [19]. There is an enormous
g a pb e t w e e nt h es p a r s ep o p u l a t i o n - b a s e dd a t as of a r
available on chronic NCDs and the comprehensive data
needed for a good understanding of their distribution in
Africa. Baseline data are needed, for example, on the
prevalence of diabetes, hypertension and obesity as well
as related cardiovascular disease risk factors in both
rural and urban settings.
Prospective cohort studies are important in epidemio-
logical research on health transition. They have made
enormous contributions, for example, to our under-
standing of the dynamics and impact of the HIV epi-
demic [20]. In populations in developed countries,
prospective cohort studies have proved crucial in under-
standing the aetiology, course and outcome of NCDs in
have informed the design of prevention programmes,
and are a valued long-term investment in public health.
In Africa prospective cohort studies on NCDs and their
risk factors can contribute to a better understanding of
NCD aetiology, course and outcome [21]. In addition to
the use of cohort studies to investigate a range of NCDs
and their risk factors over the course of an individual’s
lifetime, long-term follow-up would also enable investi-
gation of inter-generational health effects, e.g. the rela-
tionships between maternal health and nutrition status,
intrauterine growth and susceptibility to cardiovascular
and metabolic diseases. Although NCDs cause a large
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are very few prospective cohort studies on NCDs in devel-
oping countries in the region: the Birth to Twenty Cohort
in Johannesburg-Soweto (South Africa), the Heart of
Soweto Study on cardiovascular disease, and the Women’s
Health Study in Accra (Ghana) [22]. In meeting the urgent
need for longitudinal cohort studies on NCDs in Africa,
well established population-based study sites are ideal,
since they offer cost savings [21]. The population-based
cohort study in rural Masaka District in Uganda is a good
example of how a population-based study site, in this case
initially established for HIV epidemiology research, can be
successfully used as a platform for research on health tran-
sition by expanded the research scope to include chronic
NCD epidemiology [22].
Health delivery research
Although research in Africa has made a substantial con-
tribution to progress in improving the delivery of effec-
tive interventions against communicable diseases such
as HIV, tuberculosis and malaria, research on NCDs has
lagged behind that on communicable diseases. An effec-
tive response to health transition requires research on
delivering effective interventions for NCDs as well as for
communicable diseases. Cost-effective interventions for
chronic NCDs are available [23] and successful primary
care approaches to NCD care in developing countries
have been developed (e.g. a model in rural South Africa)
[24]. As the health service entry point for the vast
majority of people, primary care is the key element in
the health system response to health transition, playing
a pivotal role in the delivery of prevention and care
interventions for communicable diseases and NCDs
[15]. In place of the current approach to primary care of
people with chronic NCDs, which is often unstructured
and inadequate, a programmatic public health frame-
work for NCDs has been proposed [25] which builds on
t h ee x p e r i e n c eo fs t a n d a r d i zed diagnostic and manage-
ment protocols and information management systems
for HIV and tuberculosis interventions [26]. The
response to health transition may be improved through
the development of primary care services that cut across
conventional categories of communicable diseases and
NCDs. Health system research is needed on the effec-
tiveness of these proposals for an improved response to
health transition and on scaling-up effective approaches
in large-scale delivery programmes [15].
Policy research
Research on health intervention delivery programmes
complements the more upstream, policy-oriented
research priorities identified through a “grand challenge”
exercise [27]. Evaluation of the relevance and effective-
ness of these global policy research priorities is
necessary in different settings, including in Africa as
part of the overall research agenda for health transition.
Conclusions
While global attention on health transition has largely
been on India and China [28], we should take the
advancing wave of health transition in Africa seriously.
It is time to capitalise on the global policy environment
becoming more favourable to action on health transition
in Africa [29,30] and implement a research agenda on
health transition which builds on the well established
research agenda for communicable diseases such as HIV
[31] and malaria [32] and on recent contributions to the
agenda for NCDs [16]. Alliances such as the Global Alli-
ance for Chronic Diseases [28] have a key role to play in
Africa as well as in other regions by building research
capacity and mobilizing the necessary investments [33].
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